chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Week 1: feverish, highest measured 100.3, the nausea was really bad, diarrhea, disorientation, brain fog lethargic and fatigued, body aches, swollen lephnodes Week 2: a few good days, the nausea persisted and diarrhea, body aches, rashes springing up and down the body after 3 days the rashes subsided to just the injection site, largest rash was under left armpit, low level difficulty breathing and sharp pains in the right side Week3: general fatigue, brain feels like a mixture of vertigo and like out of body feeling disoriented, usually when this happens a flare up of nausea comes thereafter - not sure if loss of appetite is from trying to avoid nausea or that I've actually lost my appetite
tested positive for covid-19; A spontaneous report  was received from a Reporter concerning about a female patient who received Moderna's COVID-19 vaccine (mRNA-1273)  The patient's medical history was not provided. No relevant concomitant medications were reported.  Consumer received the first dose of the Moderna Covid-19 vaccine and tested positive for covid. She is a student and wants to know how this will affect anything. No treatment details were provided  Action taken with mRNA-1273 in response to the events was not reported.
I had a painful stiff neck, the back of my head hurt and there was a slight headache and the stiff neck was the most painful I've ever head. It lasted several days.
it is reddish, raised, warm and numb; small spot at the injection site / it is reddish, raised, warm and numb; it is reddish, raised, warm and numb /  2.5-3 inch swollen circle at the injection site; it is reddish, raised, warm and numb; This spontaneous case was reported by an other caregiver and describes the occurrence of INJECTION SITE WARMTH (small spot at the injection site / it is reddish, raised, warm and numb), INJECTION SITE HYPOAESTHESIA (it is reddish, raised, warm and numb), INJECTION SITE SWELLING (it is reddish, raised, warm and numb /  2.5-3 inch swollen circle at the injection site) and INJECTION SITE ERYTHEMA (it is reddish, raised, warm and numb) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and FOMEPIZOLE for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced INJECTION SITE WARMTH (small spot at the injection site / it is reddish, raised, warm and numb), INJECTION SITE HYPOAESTHESIA (it is reddish, raised, warm and numb), INJECTION SITE SWELLING (it is reddish, raised, warm and numb /  2.5-3 inch swollen circle at the injection site) and INJECTION SITE ERYTHEMA (it is reddish, raised, warm and numb). At the time of the report, INJECTION SITE WARMTH (small spot at the injection site / it is reddish, raised, warm and numb), INJECTION SITE HYPOAESTHESIA (it is reddish, raised, warm and numb), INJECTION SITE SWELLING (it is reddish, raised, warm and numb /  2.5-3 inch swollen circle at the injection site) and INJECTION SITE ERYTHEMA (it is reddish, raised, warm and numb) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No laboratory details were  provided.  No treatment medications were reported.    Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: TCR: Outcome of AE updated
Mild chills; mild to moderate body aches; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 15:00 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 12Mar2021 at 14:45 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. The patient previously took prednisone (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced allergy. On 01Apr2021 at 20:30, the patient experienced mild chills and mild to moderate body aches 5-6 after vaccine which lasted about 36 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of mild chills and mild to moderate body aches was resolved on 03Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Initial pain and swelling at site immediately after injection, however those symptoms did improve. Approximately 4 days after injection the swelling got worse, pain increased with difficulty moving arm.
Patient reported:  fast heartbeat, bad rash all over body, dizziness / weakness, shaking, full body tremor, severe itching - within 4 hours of receiving vaccination - went to Emergency Department. This is a pleasant 22-year-old female with past medical history of anxiety and depression who presents for possible allergic reaction.  Patient states that at 12:08 p.m. just prior to arrival she received the 2nd COVID-19 vaccine.  She states that immediately following the administration of this she became hot, flushed and sweaty.  She then began having itching and hives.  She denies any difficulty breathing.  She denies any swelling of the lips or tongue.  No difficulty swallowing.  No shortness of breath or chest pain.  No recent illness.  No nausea or vomiting.  Patient is a nonsmoker and denies alcohol or drug use.  She denies pregnancy with a history of IUD.Clinical presentation concerning for allergic reaction.  This is a 22-year-old female who developed itching, rash and throat tightness following her 2nd COVID-19 vaccine.  Patient is hemodynamically stable.  She is anxious in appearance.  No obvious edema of the lips or tongue.  No respiratory distress.  No stridor.  She is 98% on room air.  In IVs immediately established.  She is given 125 mg of Solu-Medrol, 20 Pepcid and 50 of Benadryl.  Following all of her medications, she no longer has any of her symptoms.  Her rash and hives has completely resolved.  I discussed this with Dr. who was in agreement that she is stable for discharge.  She will be sent home on additional 3 day course of prednisone to be started tomorrow, clear 10 for 10 days and Pepcid for 10 days.  Questions addressed and answered prior to discharge.  Patient discharged home in stable condition.
Pt given H1N1/seasonal March 8th, developed uncomplicated HSP (with no renal or other systemic manifestations) on March 24-26. Although there is a 2 1/2 week gap, we found no other obvious associated potential triggers.
Pt states redness and bumps on upper arm, axilla, and shoulder which appeared on 2/23/19 and have steadily cleared since that time. Pt also cites mild pain and soreness of upper arm, axilla, and shoulder.
GIVEN A FLU SHOT ON 10/09/07, FOLLOWED BY REDNESS AND ITCHING AT THE INJECTION SITE, SCRATCHY THROAT AND WHILE IN TRIAGE PATIENT BECAME A LITTLE LIGHTHEADED.
Initial erythema and swelling of site day after vaccine. Refusal to move leg or bear weight started 2 days after vaccine. Symptoms are now for 24 hours.
parents report that child started throwing up about 30 min after flu mist was given times 3; also had some watery yellow diarrhea.
Injection site: hot, swollen, red, hard for 3 days after the injection. 04/09/21: 99.9 fever, cold chills, body aches/muscle pain, tired, nausea, headache 04/10/21: nausea 04/11/21: nausea
This spontaneous report was received from a healthcare worker reporting on an unknown number of patients of an unknown age and gender, that since 13-JAN-2015, had bene vaccinated with a dose of VARIVAX (Merck) (dose, dose umber, lot number, expiration date and route were not reported), which underwent supported temperature excursions. No adverse effects reported. Co-suspect and concomitant therapies were not reported. Additional information has been requested. This is one (1) of two (2) reports from the same source.
started with SOB, then got terrible pain in left leg, had called 911 taken to hospital and was Diagnosed with 2 Pulmonary Embolism  and 2  deep vein thrombosis in the right leg and foot drop of the left foot, numbness of the left leg and foot.
Initial reaction was a large circle of raised, itching skin around the injection site. Rash including shingles like blisters across my chest and on my legs. Itching around my face and neck. At the one week mark, I had the first panic episode.  Since this time, I have had additional panic attacks.  I have never been prone to anxiety related issues prior to the Moderna vaccine.
PATIENT AWOKE NEXT MORNING WITH UPSET STOMACH AND FEVER OF 100.6'F.  WAS GIVEN MOTRIN. FEVER CONTINUED ON AND OFF THROUGH THE NEXT DAY AND HALF.
Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Headache-Medium, Systemic: Hypertension-Medium, Systemic: Nausea-Mild, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Tachycardia-Medium, Additional Details: numbness on left side of face and neck
Injection site bruising on left arm Injection site pain on left arm Chills Fatigue Headache Muscle pain Joint pain Diarrhea
My left arm is swelled up and bright red and I had a fever of 102.6 for 2 days My arm is still swelled up and red
Numbness in thumb; Legs felt heavy; Balance was off; Could barely move; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (Balance was off), HYPOKINESIA (Could barely move), HYPOAESTHESIA (Numbness in thumb), LIMB DISCOMFORT (Legs felt heavy) and PAIN IN EXTREMITY (Sore arm) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 09-Feb-2021, the patient experienced BALANCE DISORDER (Balance was off), HYPOKINESIA (Could barely move) and LIMB DISCOMFORT (Legs felt heavy). On 10-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness in thumb). On 06-Feb-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, BALANCE DISORDER (Balance was off), HYPOKINESIA (Could barely move), HYPOAESTHESIA (Numbness in thumb) and LIMB DISCOMFORT (Legs felt heavy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Headache; Joints hurt; Spot where the injection was is also hurting; fever; This is a spontaneous report from a contactable consumer (patient). A 54-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number ELI284), via an unspecified route of administration on 23Dec2020 at single dose for covid-19 immunization. Vaccine location was left arm and it was the first dose. Medical history included couple of months ago patient had the shingles but he don't know it's been gone. There were no concomitant medications. Patient woke up this morning (24Dec2020) with a headache, he didn't think it's quite a fever and joints that hurt and the spot where the injection was also hurting. Patient didn't received treatment. The action taken in response to the events for bnt162b2 was not applicable. The outcome of events was unknown.
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 51-year-old female patient who received SHINGRIX for prophylaxis. In July 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced influenza-like symptoms, chills and upset stomach. On an unknown date, the outcome of the influenza-like symptoms, chills and upset stomach were unknown. It was unknown if the reporter considered the influenza-like symptoms, chills and upset stomach to be related to SHINGRIX. Additional information received as follows: The patient experienced flu like symptoms which included chilling and stomach upset.
Moderna COVID-19 Vaccine EUA - lost ability to walk, feed self - this from someone with Alzheimer's disease and who was frail and an extreme fall risk. However, the severe downturn exactly one week after the shot made us wonder if it caused this significant decline.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions or medical histories provided. Concomitant therapies included sterile diluent. On unknown dates between 23-MAY-2018 and 28-JUN-2018, the patients were vaccinated with improperly stored doses of PROQUAD lot # N028444, expiration date: 09-APR-2019 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 15 to 46 degrees Fahrenheit for 2.5 hours. Data logger was involved. There was a previous excursion of 15 to 46 degrees Fahrenheit for 3 hours.
The patient started itching around the site of the injection.  Upon inspection, it was noted that there was an area that was pink and raised similar to a rash.  The patient was given 50mg of diphenhydramine and monitored for 15minutes.  The patient reported the itching has stopped and the rash was significantly less that when originally identified.
9-5-08 T102- Had vaccine 9-2-08 Diagnosed with Coxsackie and pharyngitis on 9-5-08
started w/low grade temp 99.8 to 100.3, painful joints on lt side of body inj side;painful wrists, hip, ankle & shoulders;swollen lymph nodes on lt side of face by ear & down lt side of neck;this lasted 5 days w/gen malaise;
From correspondence received on 11/07/01, it was reported that a 24 year  old male patient a Fluzone SV '01-01 vaccination administered on 11/05/01 at 1 pm. Twenty-one days later at approximately 6 pm, he developed excessive achiness in joints and long muscles, and nausea. Patient was seen in student health office, vital signs were stable.
The vaccine was administered a month too soon. This patient should have received this booster shot in February, 5 months after her 2nd dose in September.
Normal side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Normal side effects) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Normal side effects). At the time of the report, VACCINATION COMPLICATION (Normal side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information not provided.  Treatment information not provided.   Reporter did not allow further contact
Severe fatigue, nausea, vomiting, diarrhea, confusion, moderate headache and complete inability to move left arm/shoulder/hand.
No additional AE; Medical assistant reported PROQUAD was administered after a temperature excursion to multiple patients. This case is for patient two of four.; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not reported.  On unknown date, vaccines measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (recombinant Human albumin [rHA]) underwent temperature excursion at 5.56 degrees Fahrenheit for 9 hours and 30 minutes. There was no previous temperature excursion.  On 03-AUG-2022, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) subcutaneous injection, once, lot #W010061, expiration date: 20-SEP-2023 (strength, dose, and route of administration were not provided), administered for prophylaxis (product storage error). There was no additional adverse event reported.  This is one of four reports received from the same reporter.
acute inflammatory process; difficult walking; This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (acute inflammatory process) and GAIT DISTURBANCE (difficult walking) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in October 2021.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLAMMATION (acute inflammatory process) and GAIT DISTURBANCE (difficult walking). At the time of the report, INFLAMMATION (acute inflammatory process) and GAIT DISTURBANCE (difficult walking) outcome was unknown.            No concomitant medications were reported.  It was reported that patient cannot have booster from Moderna.  No treatment medications were provided.
Patient and mother specify that after the vaccine administration the patient felt very severe pain and the arm was immobilized. The arm was warm in the area near the vaccination (deltoid) and cold in the distant extremity (the wrist and forearm). Did not observe the red area nor the fast heartbeat.  The symptoms lasted for 5 days.
Information has been received from a physician concerning an 8 year old male who on 24-OCT-2002 was vaccinated with the first dose of MMR II. On 21-NOV-2005 the patient was vaccinated with the second dose of MMR II. On 09-JAN-2010 the patient experienced mumps. Date of mumps diagnosis was reported as 10-JAN-2010. The patient had right parotitis. The patient was afebrile. On 12-JAN-2010, the first blood work revealed IgM <1:10, IgG 7.55, and serum amylase 54. At the time of this report, the patient's outcome was not reported. No further information is available.
Round, raised, erythematous, maculopapular, confluent red rash approx. 5 inches in circumference circumventing injection site on right lateral thigh. Rash lasted 3 days without any specific treatements. Was painful or pruritic per toddler.
My son got Covid first he is full vaccinated. I started feeling unwell and we all took Covid tests few days later I tested positive. I didn't take any medication just cold medication to manage the symptoms.
This spontaneous report was received from an unspecified health professional and refers to a 4 year old male patient. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On 13-NOV-2017, the patient was vaccinated with an improperly stored dose number 1 of PROQUAD lot # M043307, expiration date 24-APR-2018, by subcutaneous route in the left thigh for prophylaxis. Previous temperature excursions were detected and the digital data logger was involved (product storage error). Additionally it was reported that the patient did not have any illness at the time of vaccination and no other vaccinations were administered within 4 weeks prior to this date. On 13-NOV-2017, reported by the patient's mother, he got sick following vaccination (malaise). This event was reported to an unspecified doctor and the patient recovered from the event on an unknown date. The reporter did not assess the causal relationship between therapy with PROQUAD and the aforementioned event. This is one of several reports received from the same reporter (MARRS # 1712USA003118); Sender's Comments: US-009507513-1712USA003118.
Weakness, fatigue,  injection  site sore,  clouded thought process. Slept for 10 hours. Woke up to no other symptoms  except  sore arm.
Patient received vaccination at a vaccine event. The following day she experienced soreness at the injection site. Over the next couple of days she experienced flu like symptoms. One week later, today, patient complains of a large area of redness and swelling.
Day after vaccination given Pt experienced pain in joint bone where shot was given having difficult time moving arm/sore.
Sweating; Nausea; Sore throat; Stomach ache; Pain; Chills; Fever; Tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), OROPHARYNGEAL PAIN (Sore throat), ABDOMINAL PAIN UPPER (Stomach ache), HYPERHIDROSIS (Sweating) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced PAIN (Pain), CHILLS (Chills), PYREXIA (Fever) and FATIGUE (Tired). On 08-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), ABDOMINAL PAIN UPPER (Stomach ache) and NAUSEA (Nausea). On 09-Mar-2021, the patient experienced HYPERHIDROSIS (Sweating). At the time of the report, PAIN (Pain), OROPHARYNGEAL PAIN (Sore throat), ABDOMINAL PAIN UPPER (Stomach ache), HYPERHIDROSIS (Sweating), NAUSEA (Nausea), CHILLS (Chills), PYREXIA (Fever) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications include Cold and Flu medication for symptoms. Concomitant medication include Cold and flu for an unknown indication.
18 month old female dev. R upper thigh cellulitis after receiving DTaP and varicella vaccine at that site on 9/25/02. Pt was treated with Augmentin 200mg/5ml x 7 days. Pt improved with Augmentin.
I received deep purple discoloration around vaccine site about 8 days after initial vaccination. The discoloration stayed for approx. 2 days and began to slowly degrade.
Pt. had loss of consciousness with tonic-clonic movements of limbs, eyes fixed, unresponsive to verbal stimuli.
(1) Eyes became bloodshot. (2) C/O Dizziness. (3) Became non-responsive and 911 called - was hypotensive. Taken to Cardiac ER - IV in R forearm.
Patient presented back to Primacy Care Clinic one week  following flu shot administration with reports of right  upper arm pain with erythema.  SkinRash & Pain.
Swelling 3" area, at injection site, told patient to use ice. Patient also contacted her MD and MD agreed with ice. Pt. also complained about area being warm, but not painful.
Erythema & swelling of (L) thigh on 10/10/19. Leg swollen & tense sian, warm to touch, No pain, no itching, no drainage. No fever. No trouble ambulating
Mild, just want to contribute to information for future.  Body aches mild, no appetite, felt weird, bit tired, sore arm but no more so than any other vaccine